Design, synthesis and biological evaluation of novel benzothiazole derivatives bearing semicarbazone moiety as antitumor agents

Abstract

A series of novel benzothiazole derivatives bearing semicarbazone as a linker was designed and synthesized, and their in vitro antitumor activities were evaluated against four cancer cell lines(HT29, H460, A549 and MDA-MB-231). Most of them showed moderate to excellent activity against all the tested cell lines. Among them, compounds 12a―12i with fluoro-substituted benzyl-1H-indole moiety displayed more potent activity than those with phenyl moiety. The most promising compound 12d exhibited excellent antitumor activity with IC₅₀ values of 0.015, 0.28, 1.53 and 0.68 μmol/L against the four tested cell lines respectively.

Keywords

Benzothiazole / Semicarbazone / Antitumor activity

References

[1] WHO Media Centre Cancer Feb. 8, http://www. who.int/ mediacentre/factsheets/fs297/en/

[2] Das J., Moquin R. V., Lin J., Liu C., Doweyko A. M., DeFex H. F., Fang Q., Pang S., Pitt S., Shen D. R. Bioorg. Med. Chem. Lett., 2003, 13(15): 2587.

[3] Yamazaki K., Kaneko Y., Suwa K., Ebara S., Nakazawa K., Yasuno K. Biorg. Med. Chem., 2005, 13(7): 2509.

[4] Henriksen G., Hauser A. I., Westwell A. D., Yousefi B. H., Schwaiger M., Drzezga A., Wester H. J. J. Med. Chem., 2007, 50(6): 1087.

[5] Yoshida M., Hayakawa I., Hayashi N., Agatsuma T., Oda Y., Tanzawa F., Iwasaki S., Koyama K., Furukawa H., Kurakata S. Bioorg. Med. Chem. Lett., 2005, 15(14): 3328.

[6] Kashiyama E., Hutchinson I., Chua M. S., Stinson S. F., Phillips L. R., Kaur G., Sausville E. A., Bradshaw T. D., Westwell A. D., Stevens M. F. J. Med. Chem., 1999, 42(20): 4172.

[7] Kamal A., Tamboli J. R., Nayak V. L., Adil S., Vishnuvardhan M., Ramakrishna S. Bioorg. Med. Chem. Lett., 2013, 23(11): 3208.

[8] Qin M. Z., Zhai X., Xie H., Ma J. J., Lu K., Wang Y., Wang L., Gu Y. C., Gong P. Eur. J. Med. Chem., 2014, 81: 47.

[9] Liu Z. J., Wu S. S., Wang Y., Li R., Wang J., Wang L., Zhao Y. F., Gong P. Eur. J. Med. Chem., 2014, 87: 782.

[10] Qi B. H., Mi B., Zhai X., Xu Z., Zhang X., Tian Z. R., Gong P. Biorg. Med. Chem., 2013, 21(17): 5246.

[11] Zhai X., He Y., Yang Z., Gong P. Chem. Res. Chinese Universities, 2013, 29(1): 62.

[12] Ma J. J., Chen D., Lu K., Wang L. H., Han X. Q., Zhao Y. F., Gong P. Eur. J. Med. Chem., 2014, 86: 257.

[13] Wu S., Wang L., Guo W., Liu X., Liu J., Wei X., Fang B. J. Med. Chem., 2011, 54(8): 2668.

[14] Guo W., Wu S., Wang L., Wang R. Y., Wei X., Liu J., Fang B. Mol. Cancer Ther., 2009, 8(2): 441.

[15] Bacher G., Nickel B., Emig P., Vanhoefer U., Seeber S., Shandra A., Klenner T., Beckers T. Cancer Res., 2001, 61(1): 392.

[16] Patel R. V., Patel P. K., Kumari P., Rajani D. P., Chikhalia K. H. Eur. J. Med. Chem., 2012, 53: 41.

[17] Thirumurugan R., Sriram D., Saxena A., Stables J., Yogeeswari P. Biorg. Med. Chem., 2006, 14(9): 3106.